Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Herpes simplex virus recombination vectors designed to allow insertion of modified promoters into transcriptionally “neutral” segments of the viral genome

Abstract

The use of recombinant viruses has been essential in investigation of the biology of herpes simplex virus (HSV). In this communication we describe a number of viral recombination vectors that we have generated for use in promoter structure/function analysis within the context of the HSV-1 genome. We have utilized two regions of the HSV genome that contain genes nonessential for replication in cultured cells—the glycoprotein C (gC or UL44) locus in the UL of the genome and the area encompassing the promoter and 5′ portion of the latency associated transcript (LAT) within the RL. The vectors were designed to allow insertion in either orientation within the loci to prevent an artifactual influence on promoters due to the site of insertion. Two different kinetic promoters were analyzed, those controlling expression of the γ UL38 and the β dUTPase genes, in both loci. All constructs tested displayed reporter gene mRNA expression with expected kinetics, and we conclude that there are no neighboring cryptic promoter elements that could interfere with expression studies using the vectors described.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Wagner E.K. in Webster R.G. and Granoff A. (eds.) inEncyclopedia of Virology. Academic Press, London, 1994, p. 593.

  2. 2.

    Wagner E.K. in Roizman B. (ed.)The Herpesviruses, Vol. III. Plenum Press, New York, 1985, p. 45.

  3. 3.

    Wagner E.K., Guzowski J.F., and Singh J. in Cohen W.E. and Moldave K. (eds.)Progress in Nucleic Acid Research and Molecular Biology. Academic Press, San Diego, 1995, in press.

  4. 4.

    Snowden B.W., Blair E.D., and Wagner E.K., Virus Genes2 129, 1988.

  5. 5.

    Flanagan W.M. and Wagner E.K., Virus Genes1 61, 1987.

  6. 6.

    Blair E.D., Blair C.C., and Wagner E.K., J Virol61 2499, 1987.

  7. 7.

    Blair E.D. and Wagner E.K., J Virol60 460, 1986.

  8. 8.

    Draper K.G., Devi-Rao G.B., Costa R.H., Blair E.D., Thompson R.L., and Wagner E.K., J Virol57 1023, 1986.

  9. 9.

    Batchelor A.H. and O'Hare P., J Virol64 3269, 1990.

  10. 10.

    Mavromara-Nazos P., Silver S., Hubenthal Voss J., McKnight J.L., and Roizman B., Virology149 152, 1986.

  11. 11.

    Costa R.H., Draper K.G., Devi-Rao G.B., Thompson R.L., and Wagner E.K., J Virol56 19, 1985.

  12. 12.

    Everett R.D., J Mol Biol203 739, 1988.

  13. 13.

    Ace C.I., Dalrymple M.A., Ramsay F.H., Preston V.G., and Preston C.M., J Gen Virol69 2595, 1988.

  14. 14.

    Everett R.D., EMBO J6 2069, 1987.

  15. 15.

    Johnson P.A. and Everett R.D., Nucleic Acids Res14 8247, 1986.

  16. 16.

    McKnight S.L., Cold Spring Harbor Symp Quant Biol47 945, 1983.

  17. 17.

    Roberts M.S., Boundy A., O'Hare P., Pizzorno M.C., Ciufo D.M., et al., J Virol62 4307, 1988.

  18. 18.

    Blair E.D. and Snowden B.W. in Wagner E.K. (ed.)Herpesvirus Transcription and its Regulation. CRC, Boca Raton, FL, 1991, p. 181.

  19. 19.

    Lillycrop K.A., Dent C.L., Wheatley S.C., Beech M.N., Ninkina N.N., Wood J.N., and Latchman D.S., Neuron7 381, 1991.

  20. 20.

    Everett R.D., EMBO J3 3135, 1984.

  21. 21.

    O'Hare P. and Hayward G.S., Cancer Cells4 175, 1986.

  22. 22.

    Campbell M., Palfreyman J., and Preston C.M., J Mol Biol18 1, 1984.

  23. 23.

    Everett R.D., Nucleic Acids Res7 3037, 1984.

  24. 24.

    McKnight S.L., Cell31 355, 1982.

  25. 25.

    McKnight S.L. and Tjian R., Cell46 795, 1986.

  26. 26.

    Latchman D.S. in Becker Y. and Darai G. (eds.)Pathogenecity of Human Herpesviruses due to Specific Pathogenity Genes. Springer-Verlag, Berlin, 1994, p. 238.

  27. 27.

    Hayward G.S., Semin Virol4 15, 1993.

  28. 28.

    Smiley J.R., Johnson D.C., Pizer L.I., and Everett R.D., J Virol66 623, 1992.

  29. 29.

    Huang C. and Wagner E.K., J Virol68 5738, 1994.

  30. 30.

    Flanagan W.M., Papavassiliou A.G., Rice M., Hecht L.B., Silverstein S.J., and Wagner E.K., J Virol65 769, 1991.

  31. 31.

    Goodart S.A., Guzowski J.F., Rice M.K., and Wagner E.K., J Virol66 2973, 1992.

  32. 32.

    Guzowski J.F. and Wagner E.K., J Virol67 5098, 1993.

  33. 33.

    Huang C., Goodart S.A., Rice M.K., Guzowski J.F., and Wagner E.K., J Virol67 5109, 1993.

  34. 34.

    Hall L.M., Draper K.G., Frink R.J., Costa R.H., and Wagner E.K., J Virol43 594, 1982.

  35. 35.

    Huang C., Rice M.K., Devi-Rao G.B., and Wagner E.K., J Virol68 1972, 1994.

  36. 36.

    Gilman M. in Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., et al. (eds.)Current Protocols in Molecular Biology. Wiley-Interscience, New York, 1989, p. 4.7.1.

  37. 37.

    Guzowski J.F., Singh J., and Wagner E.K., J Virol68 7774, 1994.

  38. 38.

    Kibler P.K., Duncan J., Keith B.D., Hupel T., and Smiley J.R., J Virol65 6749, 1991.

  39. 39.

    MacLean C.A., Efstathiou S., Elliott M.L., Jamieson F.E., and McGeoch D.J., J Gen Virol72 897, 1991.

  40. 40.

    Roizman B., Science239, G110, 1988.

  41. 41.

    Arsenakis M., Campadelli-Fiume G., and Roizman B., J Virol62 148, 1988.

  42. 42.

    Jenkins F.J. and Roizman B., Bioessays5 244, 1986.

  43. 43.

    Silver S. and Roizman B., Mol Cell Biol5 518, 1985.

  44. 44.

    Spector D., Purves F., and Roizman B., Proc Natl Acad Sci USA87 5268, 1990.

  45. 45.

    Mavromara-Nazos P. and Roizman B., Proc Natl Acad Sci USA86 4071, 1989.

  46. 46.

    Homa F.L., Otal T.M., Glorioso J.C., and Levine M., Mol Cell Biol6 3652, 1986.

  47. 47.

    Weir J.P. and Narayanan P.R., J Virol64 445, 1990.

  48. 48.

    Steffy K.R. and Weir J.P., J Virol65 972, 1991.

  49. 49.

    Homa F.L., Krikos A., Glorioso J.C., and Levine M. in Wagner E.K. (ed.)Herpesvirus Transcription and its Regulation. CRC, Boca Raton, FL, 1991, p. 207.

  50. 50.

    Steffy K.R. and Weir J.P., J Virol65 6454, 1991.

  51. 51.

    Sethna M. and Weir J.P., Virology196 532, 1993.

  52. 52.

    Campadelli-Fiume G., Stirpe D., Boscaro A., Avitabile E., Foa-Tomasi L., Barker D., and Roizman B., Virology178 213, 1990.

  53. 53.

    Herold B.C., WuDunn D., Soltys N., and Spear P.G., J Virol65 1090, 1991.

  54. 54.

    Toh Y., Tanaka S., Liu Y., Hidaka Y., and Mori R., Arch Virol129 119, 1993.

  55. 55.

    Sedarati F., Izumi K.M., Wagner E.K., and Stevens J.G., J Virol63 4455, 1989.

  56. 56.

    Javier R.T., Stevens J.G., Dissette V.B., and Wagner E.K., Virology166 254, 1988.

  57. 57.

    Stevens J.G., Semin Virol5 191, 1994.

  58. 58.

    Sedarati F., Margolis T.P., and Stevens J.G., Virology192 687, 1993.

Download references

Author information

Correspondence to Edward K. Wagner.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Singh, J., Wagner, E.K. Herpes simplex virus recombination vectors designed to allow insertion of modified promoters into transcriptionally “neutral” segments of the viral genome. Virus Genes 10, 127–136 (1995). https://doi.org/10.1007/BF01702593

Download citation

Key words

  • HSV
  • recombinant
  • promoter